Articles by Richard Altus, ImpactRx - Pharmaceutical Executive

ADVERTISEMENT

Articles by Richard Altus, ImpactRx

Richard Altus, ImpactRx


Avandia Sales Away
July 30, 2007

Avandia's market share erosion was magnified further by the almost complete absence of new prescriptions being switched to Avandia from its competitors. In the weeks before the event, Avandia accounted for more than 20 percent of all switches by primary care physicians

ADVERTISEMENT

Click here